Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMANX: Validation of TEMA Test System with Naltrexone for Alcoholism
NCT02652585Phase 3Completed
- Sponsor
- Technische Universität Dresden
- Start
- Feb 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in alcohol use disorder (AUD), sponsored by Technische Universität Dresden. Started Feb 2016; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02652585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02652585.